These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3562851)

  • 1. Functional studies of cholecystokinin-dopamine co-existence: electrophysiology and behavior.
    Skirboll LR; Crawley JN; Hommer DW
    Prog Brain Res; 1986; 68():357-70. PubMed ID: 3562851
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholecystokinin (CCK): ascension from gut to brain.
    Psychopharmacol Bull; 1983; 19(3):347-63. PubMed ID: 6314422
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracerebroventricular administration of cholecystokinin inhibits the activity of the dopaminergic and serotoninergic systems of the brain.
    Vasar EE; Otter MYa ; Ryago LK
    Neurosci Behav Physiol; 1985; 15(3):232-6. PubMed ID: 2993947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cholecystokinin on dopamine metabolism in the rat brain].
    Kogan BM; Khristoliubova NA; Anokhin KV
    Biull Eksp Biol Med; 1982 Aug; 94(8):42-3. PubMed ID: 7126854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intracerebroventricular administration of cholecystokinin inhibits the dopamine- and serotoninergic systems of the brain].
    Vasar EE; Otter MIa; Riago LK
    Fiziol Zh SSSR Im I M Sechenova; 1982 Sep; 68(9):1218-22. PubMed ID: 7173435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's disease.
    Diamond BI; Pasinetti G; Hitri A; Borison RL
    Adv Neurol; 1984; 40():483-8. PubMed ID: 6695625
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-activity studies concerning effect of cholecystokinin octapeptide on passive avoidance behaviour of rats.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(3):197-200. PubMed ID: 6291320
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of cholecystokinin octapeptide sulphate ester and unsulphated cholecystokinin octapeptide on active avoidance behaviour in rats.
    Fekete M; Bokor M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(1-2):57-63. PubMed ID: 6306996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin potentiates dopamine-mediated behaviors in the nucleus accumbens, a site of CCK-DA co-existence.
    Crawley JN
    Psychopharmacol Bull; 1985; 21(3):523-7. PubMed ID: 4034868
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion.
    Crawley JN
    Synapse; 1989; 3(4):346-55. PubMed ID: 2740993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
    Hasan F; Leonard BE
    Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned rat.
    Kroin JS; Kao LC; Zhang TJ; Penn RD; Klawans HL; Carvey PM
    J Neurosurg; 1991 Jan; 74(1):105-11. PubMed ID: 1984488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of clonidine with dopamine-dependent behaviours in rodents [proceedings].
    Jenner PG; Pycock CJ
    Br J Pharmacol; 1976 Nov; 58(3):469P. PubMed ID: 990644
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of the administration of various cholecystokinin fragments on dopamine release in basal ganglia: a microdialysis study in halothane anesthetized rats].
    Ruggeri M
    Ann Ist Super Sanita; 1988; 24(4):539-42. PubMed ID: 3218802
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat.
    Debonnel G; de Montigny C
    Synapse; 1988; 2(5):537-45. PubMed ID: 2903570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the functional roles of norepinephrine, dopamine, and phenylethylamine in the central nervous system.
    Sabelli HC; Giardina WJ; Mosnaim AD; Sabelli NH
    Acta Physiol Pol; 1973; 24(1):33-40. PubMed ID: 4716347
    [No Abstract]   [Full Text] [Related]  

  • 18. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonstriatal dopaminergic neurons: Section VI. Action of dopamine at synaptic level:influence on postsynaptic cells: Introduction: action of dopamine at synaptic level: influence on postsynaptic cells.
    Iversen LL
    Adv Biochem Psychopharmacol; 1977; 16():381-3. PubMed ID: 883549
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of the central effect of dopamine on gnawing compulsion syndrome in rats and the release of serotonin.
    Ernst AM
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):219-25. PubMed ID: 4262736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.